The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWitan Regulatory News (WTAN)

Share Price Information for Witan (WTAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 263.00
Bid: 262.00
Ask: 262.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.191%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 263.00
WTAN Live PriceLast checked at -
Witan is an Investment Trust

To achieve an investment total return exceeding that of the benchmark of the Company over the longer term, together with growth in the dividend ahead of inflation through active investment in global equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviewed Witan Pacific Investment Trust

16 Dec 2019 15:46

RNS Number : 0400X
Witan Investment Trust PLC
16 December 2019
 

 

London, UK, 16 December 2019

Edison issues review on Witan Pacific Investment Trust (WPC)

Witan Pacific Investment Trust (WPC) offers broad exposure to the Asia Pacific region (including Japan), employing a multi-manager strategy. The board remains confident that the current line-up of four complementary managers is capable of good long-term outperformance; however, it has a contingency measure in place. If WPC does not outperform its benchmark in the two years ending 31 January 2021, investors will be given the opportunity to realise their holdings close to NAV, so either relative performance will improve or the trust's discount will narrow. WPC has a progressive dividend policy; its annual distribution has increased for the last 14 consecutive years and the trust currently offers a 2.1% yield.

 

WPC's discount has continued to narrow following the board's February 2019 announcement to address the trust's investment performance. Its shares are currently trading at a 9.1% discount to cum-income NAV, which is significantly lower than the 11.3%, 13.0%, 13.1% and 14.1% average discounts over the last one, three, five and 10 years respectively. The board actively repurchases shares when they are trading at a substantial and anomalous discount to NAV.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at Edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFFDFIMFUSELE
Date   Source Headline
18th Aug 202312:59 pmRNSNet Asset Value(s)
17th Aug 20234:53 pmRNSTransaction in Own Shares
17th Aug 20231:29 pmRNSNet Asset Value(s)
16th Aug 20235:22 pmRNSTransaction in Own Shares
16th Aug 202311:28 amRNSNet Asset Value(s)
15th Aug 20235:02 pmRNSTransaction in Own Shares
15th Aug 202312:06 pmRNSNet Asset Value(s)
15th Aug 20237:00 amRNSHalf-year Report
14th Aug 20235:10 pmRNSTransaction in Own Shares
14th Aug 202312:16 pmRNSNet Asset Value(s)
11th Aug 20235:49 pmRNSTransaction in Own Shares
11th Aug 202312:32 pmRNSNet Asset Value(s)
10th Aug 20235:13 pmRNSTransaction in Own Shares
10th Aug 20232:03 pmRNSMonthly Fact Sheet as at 31 July 2023
10th Aug 202312:10 pmRNSNet Asset Value(s)
9th Aug 20235:12 pmRNSTransaction in Own Shares
9th Aug 202311:08 amRNSNet Asset Value(s)
8th Aug 20235:17 pmRNSTransaction in Own Shares
8th Aug 202312:48 pmRNSNet Asset Value(s)
7th Aug 20235:06 pmRNSTransaction in Own Shares
7th Aug 202311:18 amRNSNet Asset Value(s)
4th Aug 20235:12 pmRNSTransaction in Own Shares
4th Aug 202312:10 pmRNSNet Asset Value(s)
3rd Aug 20235:03 pmRNSTransaction in Own Shares
3rd Aug 202312:47 pmRNSNet Asset Value(s)
2nd Aug 20235:10 pmRNSTransaction in Own Shares
2nd Aug 202312:27 pmRNSNet Asset Value(s)
1st Aug 20235:04 pmRNSTransaction in Own Shares
1st Aug 202312:41 pmRNSNet Asset Value(s)
1st Aug 20239:46 amRNSTotal Voting Rights
31st Jul 20235:09 pmRNSTransaction in Own Shares
31st Jul 20232:01 pmRNSNet Asset Value(s)
28th Jul 20235:08 pmRNSTransaction in Own Shares
28th Jul 202312:03 pmRNSNet Asset Value(s)
27th Jul 20235:12 pmRNSTransaction in Own Shares
27th Jul 202312:42 pmRNSNet Asset Value(s)
26th Jul 20235:03 pmRNSTransaction in Own Shares
26th Jul 202311:37 amRNSNet Asset Value(s)
25th Jul 20235:05 pmRNSTransaction in Own Shares
25th Jul 202312:02 pmRNSNet Asset Value(s)
24th Jul 20234:53 pmRNSTransaction in Own Shares
24th Jul 202311:48 amRNSNet Asset Value(s)
21st Jul 20235:10 pmRNSTransaction in Own Shares
21st Jul 202311:04 amRNSNet Asset Value(s)
21st Jul 20237:00 amRNSKepler Trust Intelligence: New Research
20th Jul 20235:11 pmRNSTransaction in Own Shares
20th Jul 202311:55 amRNSNet Asset Value(s)
20th Jul 20237:00 amRNSBlock listing Interim Review
19th Jul 20235:06 pmRNSTransaction in Own Shares
19th Jul 202311:57 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.